{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:30:27Z","timestamp":1792132227312,"version":"4.4.0"},"reference-count":141,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiovascular disease (CVD) remains a predominant cause of morbidity and mortality globally, characterized by pathological mechanisms that encompass inflammation, oxidative stress, metabolic disturbances and immune dysregulation. Recently, the influence of gut microbiota and its metabolites on the onset and progression of CVD has garnered significant attention. Short-chain fatty acids (SCFAs), particularly butyrate, are the primary products of gut microbial fermentation of dietary fiber. Butyrate is instrumental in maintaining intestinal barrier function and immune homeostasis and exhibits notable anti-inflammatory, antioxidant, and metabolic regulatory potentials in cardiovascular diseases. Nonetheless, the precise molecular mechanisms of butyrate in various cardiovascular diseases and its clinical translational value necessitate a systematic review of the literature. This study conducted a comprehensive search of databases, such as PubMed and Web of Science, to synthesize recent basic and clinical research on butyrate and cardiovascular diseases, focusing on its role in hypertension, atherosclerosis, coronary artery disease, atrial fibrillation, diabetic cardiomyopathy, and heart failure. The findings indicate that butyrate can influence cardiovascular health through multiple pathways, including the modulation of G protein-coupled receptors (GPCRs), histone deacetylases (HDACs), and peroxisome proliferator-activated receptors (PPARs). Although numerous experimental studies have corroborated the protective effects of butyrate in cardiovascular diseases, its clinical translation remains challenging owing to factors such as optimal administration route, dose optimization, and individualized treatment strategies. Future research should integrate large-scale population cohort analyses and randomized controlled trials (RCTs) to ascertain the precise efficacy of butyrate in the prevention and treatment of cardiovascular diseases and explore its potential as a novel therapeutic target.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1608658","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T06:06:15Z","timestamp":1753682775000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Recent advancements and comprehensive analyses of butyric acid in cardiovascular diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Qiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1161\/circulationaha.116.008731","article-title":"Endemic cardiovascular diseases of the poorest billion","volume":"133","author":"Kwan","year":"2016","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/nu13010144","article-title":"Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: a review","volume":"13","author":"Duttaroy","year":"2021","journal-title":"Nutrients"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.3390\/nu13082795","article-title":"Effect of diet and dietary components on the composition of the gut microbiota","volume":"13","author":"Beam","year":"2021","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11883-022-00996-x","article-title":"Overweight, obesity, and CVD risk: a focus on visceral\/ectopic fat","volume":"24","author":"Chartrand","year":"2022","journal-title":"Curr Atheroscler Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"8178","DOI":"10.3390\/ijms21218178","article-title":"Prevention of diabetes and cardiovascular disease in obesity","volume":"21","author":"La Sala","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/nyas.14107","article-title":"Gut microbiome and its role in obesity and insulin resistance","volume":"1461","author":"Lee","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.62368\/pn.v3i.30","article-title":"Protective effects of piceatannol on cardiovascular diseases","volume":"3","author":"Cheang","year":"2024","journal-title":"PHYTONutrients"},{"key":"B9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/ptr.4751","article-title":"Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-\u03b1 in hypercholesterolemic rats induced with a high-cholesterol diet","volume":"27","author":"Wan","year":"2013","journal-title":"Phytother Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro3344","article-title":"The gut microbiota, bacterial metabolites and colorectal cancer","volume":"12","author":"Louis","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"key":"B13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/cphy.c170014","article-title":"Short-chain fatty acid transporters: role in colonic homeostasis","volume":"8","author":"Sivaprakasam","year":"2017","journal-title":"Compr Physiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/gutjnl-2024-334346","article-title":"DUOX2 activation drives bacterial translocation and subclinical inflammation in IBD-associated dysbiosis","author":"Hazime","year":"2025","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.3390\/ijms21114006","article-title":"The role of histone acetylation and the microbiome in phytochemical efficacy for cardiovascular diseases","volume":"21","author":"Evans","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pharmthera.2018.11.003","article-title":"Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics","volume":"196","author":"Xu","year":"2019","journal-title":"Pharmacol Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41420-025-02491-z","article-title":"Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment","volume":"11","author":"Yang","year":"2025","journal-title":"Cell Death Discov"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.3390\/ijms23063303","article-title":"Short-chain fatty acid receptors and cardiovascular function","volume":"23","author":"Lymperopoulos","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/1440-1681.12579","article-title":"Peroxisome proliferator-activated receptors in cardiac energy metabolism and cardiovascular disease","volume":"43","author":"Ajith","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2198645","DOI":"10.1155\/2016\/2198645","article-title":"Peroxisome proliferator-activated receptor-\u03b3 is critical to cardiac fibrosis","volume":"2016","author":"Liu","year":"2016","journal-title":"PPAR Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator-activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/HYPERTENSIONAHA.120.14473","article-title":"Microbial peer pressure: the role of the gut microbiota in hypertension and its complications","volume":"76","author":"Muralitharan","year":"2020","journal-title":"Hypertension"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"key":"B24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1042\/CS20180087","article-title":"Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure","volume":"132","author":"Kim","year":"2018","journal-title":"Clin Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/HYPERTENSIONAHA.120.14800","article-title":"Modest sodium reduction increases circulating short-chain fatty acids in untreated hypertensives: a randomized, double-blind, placebo-controlled trial","volume":"76","author":"Chen","year":"2020","journal-title":"Hypertension"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e024763","DOI":"10.1161\/JAHA.121.024763","article-title":"Increases in circulating and fecal butyrate are associated with reduced blood pressure and hypertension: results from the SPIRIT trial","volume":"11","author":"Tilves","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.3390\/ijms24054955","article-title":"Clostridium butyricum prevents dysbiosis and the rise in blood pressure in spontaneously hypertensive rats","volume":"24","author":"Luo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.115.06672","article-title":"Role of the gut microbiome in obstructive sleep apnea-induced hypertension","volume":"67","author":"Durgan","year":"2016","journal-title":"Hypertension"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e13256","DOI":"10.1111\/apha.13256","article-title":"Impaired butyrate absorption in the proximal colon, low serum butyrate and diminished central effects of butyrate on blood pressure in spontaneously hypertensive rats","volume":"226","author":"Yang","year":"2019","journal-title":"Acta Physiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/HYPERTENSIONAHA.116.07910","article-title":"Increased systolic and diastolic blood pressure is associated with altered gut microbiota composition and butyrate production in early pregnancy","volume":"68","author":"Gomez-Arango","year":"2016","journal-title":"Hypertension"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/HYPERTENSIONAHA.118.12588","article-title":"Gut microbiota and fecal levels of short-chain fatty acids differ upon 24-hour blood pressure levels in men","volume":"74","author":"Huart","year":"2019","journal-title":"Hypertension"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1073\/pnas.1215927110","article-title":"Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation","volume":"110","author":"Pluznick","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1097\/hjh.0000000000001378","article-title":"Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro)renin receptor and intrarenal renin\u2013angiotensin system","volume":"35","author":"Wang","year":"2017","journal-title":"J Hypertens"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00424-019-02322-y","article-title":"Butyric acid, a gut bacteria metabolite, lowers arterial blood pressure via colon-vagus nerve signaling and GPR41\/43 receptors","volume":"471","author":"Onyszkiewicz","year":"2019","journal-title":"Pflugers Arch"},{"key":"B35","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1152\/physiolgenomics.00089.2016","article-title":"Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41","volume":"48","author":"Natarajan","year":"2016","journal-title":"Physiol Genomics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41440-020-00548-3","article-title":"Sodium butyrate ameliorates deoxycorticosterone acetate\/salt-induced hypertension and renal damage by inhibiting the MR\/SGK1 pathway","volume":"44","author":"Wu","year":"2021","journal-title":"Hypertens Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"16467","DOI":"10.1074\/jbc.M412960200","article-title":"Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase","volume":"280","author":"Gan","year":"2005","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/MNH.0000000000000862","article-title":"Targeting inflammation in hypertension","volume":"32","author":"Deussen","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e3074","DOI":"10.1038\/cddis.2017.470","article-title":"NLRP3 Inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension","volume":"8","author":"Sun","year":"2017","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/cvr\/cvy252","article-title":"Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension","volume":"115","author":"Krishnan","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"112743","DOI":"10.1016\/j.fct.2021.112743","article-title":"Sodium butyrate ameliorates neurotoxicity and exerts anti-inflammatory effects in high fat diet-fed mice","volume":"159","author":"Bayazid","year":"2022","journal-title":"Food Chem Toxicol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"12676","DOI":"10.1038\/srep12676","article-title":"Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"104451","DOI":"10.1016\/j.phrs.2019.104451","article-title":"Microglia, autonomic nervous system, immunity and hypertension: is there a link?","volume":"155","author":"Li","year":"2020","journal-title":"Pharmacol Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"114308","DOI":"10.1016\/j.biopha.2023.114308","article-title":"Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis","volume":"160","author":"Wei","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biom8030080","article-title":"Research progress on the relationship between atherosclerosis and inflammation","volume":"8","author":"Zhu","year":"2018","journal-title":"Biomolecules"},{"key":"B47","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41569-023-00957-0","article-title":"Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets","volume":"21","author":"De Meyer","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1074\/jbc.M114.618249","article-title":"Transmission of atherosclerosis susceptibility with gut microbial transplantation","volume":"290","author":"Gregory","year":"2015","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cca.2020.04.037","article-title":"Butyrate-producing bacteria and the gut-heart axis in atherosclerosis","volume":"507","author":"Chen","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41564-018-0272-x","article-title":"Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model","volume":"3","author":"Kasahara","year":"2018","journal-title":"Nat Microbiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.numecd.2014.01.002","article-title":"Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NF\u03baB activation","volume":"24","author":"Aguilar","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"115916","DOI":"10.1016\/j.biopha.2023.115916","article-title":"Bacterial butyrate mediates the anti-atherosclerotic effect of silybin","volume":"169","author":"Shen","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.redox.2018.02.007","article-title":"Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: antioxidant action of butyrate","volume":"16","author":"Yuan","year":"2018","journal-title":"Redox Biol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0282685","DOI":"10.1371\/journal.pone.0282685","article-title":"Butyrate suppresses atherosclerotic inflammation by regulating macrophages and polarization via GPR43\/HDAC-miRNAs axis in ApoE-\/- mice","volume":"18","author":"Ma","year":"2023","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"875473","DOI":"10.3389\/fnut.2022.875473","article-title":"Butyric acid ameliorates myocardial fibrosis by regulating M1\/M2 polarization of macrophages and promoting recovery of mitochondrial function","volume":"9","author":"Li","year":"2022","journal-title":"Front Nutr"},{"key":"B57","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2337\/db11-0846","article-title":"Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3","volume":"61","author":"Li","year":"2012","journal-title":"Diabetes"},{"key":"B58","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10863-020-09841-9","article-title":"Butyrate mitigates TNF-alpha-induced attachment of monocytes to endothelial cells","volume":"52","author":"Wang","year":"2020","journal-title":"J Bioenerg Biomembr"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1039241","DOI":"10.3389\/fimmu.2022.1039241","article-title":"ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jnutbio.2016.05.002","article-title":"Oral butyrate reduces oxidative stress in atherosclerotic lesion sites by a mechanism involving NADPH oxidase down-regulation in endothelial cells","volume":"34","author":"Aguilar","year":"2016","journal-title":"J Nutr Biochem"},{"key":"B62","doi-asserted-by":"publisher","first-page":"105681","DOI":"10.1016\/j.phrs.2021.105681","article-title":"Butyrate protects endothelial function through PPARdelta\/miR-181b signaling","volume":"169","author":"Tian","year":"2021","journal-title":"Pharmacol Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","article-title":"Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism","volume":"73","author":"Loboda","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3390\/ijms21134777","article-title":"NRF2, A transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.3390\/ijms24076723","article-title":"Mitigation of cardiovascular disease and toxicity through NRF2 signalling","volume":"24","author":"Roberts","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1111\/j.1742-4658.2007.06119.x","article-title":"Involvement of glutathione\/glutathione S-transferase antioxidant system in butyrate-inhibited vascular smooth muscle cell proliferation","volume":"274","author":"Ranganna","year":"2007","journal-title":"FEBS J"},{"key":"B67","doi-asserted-by":"publisher","first-page":"166984","DOI":"10.1016\/j.bbadis.2023.166984","article-title":"Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2\/GPX4 signal pathway and improving intestinal barrier","volume":"1870","author":"Chen","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/ph7111008","article-title":"Involvement of the antioxidant effect and anti-inflammatory response in butyrate-inhibited vascular smooth muscle cell proliferation","volume":"7","author":"Mathew","year":"2014","journal-title":"Pharmaceuticals"},{"key":"B69","doi-asserted-by":"publisher","first-page":"188890","DOI":"10.1016\/j.bbcan.2023.188890","article-title":"GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"116512","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, Ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B71","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jnutbio.2018.02.011","article-title":"Butyrate from pectin fermentation inhibits intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E-deficient mice","volume":"56","author":"Chen","year":"2018","journal-title":"J Nutr Biochem"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1161\/CIRCULATIONAHA.106.684704","article-title":"Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"116","author":"Babaev","year":"2007","journal-title":"Circulation"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.cellsig.2013.06.008","article-title":"Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential","volume":"25","author":"Gaidarov","year":"2013","journal-title":"Cell Signal"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/bph.14933","article-title":"Butyrate protects against high-fat diet-induced atherosclerosis via up-regulating ABCA1 expression in apolipoprotein E-deficiency mice","volume":"177","author":"Du","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40168-019-0683-9","article-title":"Alterations in the gut microbiome and metabolism with coronary artery disease severity","volume":"7","author":"Liu","year":"2019","journal-title":"Microbiome"},{"key":"B76","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jgg.2021.12.007","article-title":"The gut microbiome and microbial metabolites in acute myocardial infarction","volume":"49","author":"Liu","year":"2022","journal-title":"J Genet Genomics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41591-022-01686-6","article-title":"Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease","volume":"28","author":"Talmor-Barkan","year":"2022","journal-title":"Nat Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1016\/j.numecd.2021.06.024","article-title":"Targeted metabolomic analysis of plasma fatty acids in acute myocardial infarction in young adults","volume":"31","author":"Guo","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/circulationaha.118.035235","article-title":"Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair","volume":"139","author":"Tang","year":"2019","journal-title":"Circulation"},{"key":"B80","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1038\/s41467-023-43167-5","article-title":"Gut butyrate-producers confer post-infarction cardiac protection","volume":"14","author":"Chen","year":"2023","journal-title":"Nat Commun"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1600254","DOI":"10.1002\/advs.201600254","article-title":"PLGA-PNIPAM microspheres loaded with the gastrointestinal nutrient NaB ameliorate cardiac dysfunction by activating Sirt3 in acute myocardial infarction","volume":"3","author":"Cheng","year":"2016","journal-title":"Adv Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1139\/cjpp-2019-0531","article-title":"Butyrate improves cardiac function and sympathetic neural remodeling following myocardial infarction in rats","volume":"98","author":"Jiang","year":"2020","journal-title":"Can J Physiol Pharmacol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3892\/etm.2022.11357","article-title":"Myocardial ischemia\/reperfusion injury: mechanisms of injury and implications for management (review)","volume":"23","author":"He","year":"2022","journal-title":"Exp Ther Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1081719","DOI":"10.3389\/fimmu.2022.1081719","article-title":"Characterization of early myocardial inflammation in ischemia-reperfusion injury","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1152\/physrev.00024.2007","article-title":"Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury","volume":"88","author":"Murphy","year":"2008","journal-title":"Physiol Rev"},{"key":"B86","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/13880209.2020.1779318","article-title":"Baicalin regulates macrophages polarization and alleviates myocardial ischaemia\/reperfusion injury via inhibiting JAK\/STAT pathway","volume":"58","author":"Xu","year":"2020","journal-title":"Pharm Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3892\/etm.2014.1726","article-title":"Anti-inflammatory effect of sodium butyrate preconditioning during myocardial ischemia\/reperfusion","volume":"8","author":"Hu","year":"2014","journal-title":"Exp Ther Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3839\/jksabc.2010.088","article-title":"Tyrate and propionate, short chain fatty acids, attenuate myocardial damages by inhibition of apoptosis in a rat model of ischemia-reperfusion","volume":"53","author":"Lim","year":"2010","journal-title":"J Korean Soc Appl Biol Chem"},{"key":"B89","doi-asserted-by":"publisher","first-page":"718674","DOI":"10.3389\/fcvm.2021.718674","article-title":"Oral supplementation with butyrate improves myocardial ischemia\/reperfusion injury via a gut-brain neural circuit","volume":"8","author":"Yu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/cvr\/cvab114","article-title":"Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome","volume":"118","author":"Zhang","year":"2022","journal-title":"Cardiovasc Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.7150\/ijbs.70644","article-title":"Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43\/NLRP3 signaling","volume":"18","author":"Zuo","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1032268","DOI":"10.3389\/fendo.2022.1032268","article-title":"Diabetic cardiomyopathy: clinical phenotype and practice","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/circresaha.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/circresaha.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/j.clnu.2021.04.007","article-title":"Short-chain fatty acids combined with intronic DNA methylation of HIF3A: potential predictors for diabetic cardiomyopathy","volume":"40","author":"Guo","year":"2021","journal-title":"Clin Nutr"},{"key":"B96","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-015-0262-8","article-title":"Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice","volume":"14","author":"Chen","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"116136","DOI":"10.1016\/j.biopha.2024.116136","article-title":"Energy metabolism and redox balance: how phytochemicals influence heart failure treatment","volume":"171","author":"Chen","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1161\/CIRCULATIONAHA.120.052671","article-title":"Short-chain fatty acids outpace ketone oxidation in the failing heart","volume":"143","author":"Carley","year":"2021","journal-title":"Circulation"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e2014681118","DOI":"10.1073\/pnas.2014681118","article-title":"Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation","volume":"118","author":"Hao","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B100","doi-asserted-by":"publisher","first-page":"8139","DOI":"10.1111\/jcmm.14684","article-title":"Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2\/PGE2 pathway via a HDAC5\/HDAC6-dependent mechanism","volume":"23","author":"Zhang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e033744","DOI":"10.1161\/JAHA.123.033744","article-title":"Short-chain fatty acid butyrate is an inotropic agent with vasorelaxant and cardioprotective properties","volume":"13","author":"Seefeldt","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"B102","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00125-022-05857-5","article-title":"Cardiovascular outcomes in type 1 and type 2 diabetes","volume":"66","author":"Rosengren","year":"2023","journal-title":"Diabetologia"},{"key":"B103","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","article-title":"Diabetes, cardiovascular disease and the microcirculation","volume":"17","author":"Strain","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41569-024-01115-w","article-title":"Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches","volume":"22","author":"Khan","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"B106","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-physiol-060721-092930","article-title":"Adipose tissue fibrosis in obesity: etiology and challenges","volume":"84","author":"Marcelin","year":"2022","journal-title":"Annu Rev Physiol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B108","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/s2213-8587(16)30162-0","article-title":"Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/19490976.2018.1465157","article-title":"The human gut microbiota: metabolism and perspective in obesity","volume":"9","author":"Gomes","year":"2018","journal-title":"Gut Microbes"},{"key":"B111","doi-asserted-by":"publisher","first-page":"571731","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e2118811","DOI":"10.1001\/jamanetworkopen.2021.18811","article-title":"Association of insulin resistance and type 2 diabetes with gut microbial diversity: a microbiome-wide analysis from population studies","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.2337\/db22-0168","article-title":"Butyrate-producing bacteria and insulin homeostasis: the microbiome and insulin longitudinal evaluation study (MILES)","volume":"71","author":"Cui","year":"2022","journal-title":"Diabetes"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.2337\/diab.37.10.1405","article-title":"Sodium butyrate increases glucagon and insulin gene expression by recruiting immunocytochemically negative cells to produce hormone","volume":"37","author":"Powers","year":"1988","journal-title":"Diabetes"},{"key":"B115","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41419-022-04517-1","article-title":"Sodium butyrate potentiates insulin secretion from rat islets at the expense of compromised expression of \u03b2 cell identity genes","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B116","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.etap.2018.09.002","article-title":"Sodium butyrate mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of endoplasmic reticulum stress","volume":"64","author":"Hu","year":"2018","journal-title":"Environ Toxicol Pharmacol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"8715","DOI":"10.3390\/molecules27248715","article-title":"Sodium butyrate attenuates AGEs-induced oxidative stress and inflammation by inhibiting autophagy and affecting cellular metabolism in THP-1 cells","volume":"27","author":"Yan","year":"2022","journal-title":"Molecules"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2014.02.001","article-title":"Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38\/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat","volume":"213","author":"Khan","year":"2014","journal-title":"Chem Biol Interact"},{"key":"B119","doi-asserted-by":"publisher","first-page":"652942","DOI":"10.3389\/fendo.2021.652942","article-title":"Impact of sodium butyrate treatment in LPS-stimulated peripheral blood mononuclear cells of poorly controlled type 2 DM","volume":"12","author":"Wibowo","year":"2021","journal-title":"Front Endocrinol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1111\/bph.13058","article-title":"Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning","volume":"172","author":"Henagan","year":"2015","journal-title":"Br J Pharmacol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","article-title":"Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits","volume":"156","author":"De Vadder","year":"2014","journal-title":"Cell"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e13498","DOI":"10.1111\/obr.13498","article-title":"Butyrate to combat obesity and obesity-associated metabolic disorders: current status and future implications for therapeutic use","volume":"23","author":"van Deuren","year":"2022","journal-title":"Obes Rev"},{"key":"B124","doi-asserted-by":"publisher","first-page":"e35240","DOI":"10.1371\/journal.pone.0035240","article-title":"Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"B125","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1055\/s-0043-119089","article-title":"Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: a randomized double-blind, placebo-controlled trial","volume":"49","author":"Roshanravan","year":"2017","journal-title":"Horm Metab Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.3390\/nu12072041","article-title":"Targeting the intestinal microbiota to prevent type 2 diabetes and enhance the effect of metformin on glycaemia: a randomised controlled pilot study","volume":"12","author":"Palacios","year":"2020","journal-title":"Nutrients"},{"key":"B127","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cbi.2016.06.007","article-title":"Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: a comparative study with metformin","volume":"254","author":"Khan","year":"2016","journal-title":"Chem Biol Interact"},{"key":"B128","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00125-019-05073-8","article-title":"Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial","volume":"63","author":"De Groot","year":"2020","journal-title":"Diabetologia"},{"key":"B129","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.nut.2017.10.007","article-title":"Sodium butyrate modulates adipocyte expansion, adipogenesis, and insulin receptor signaling by upregulation of PPAR-gamma in obese apo E knockout mice","volume":"47","author":"Aguilar","year":"2018","journal-title":"Nutrition"},{"key":"B130","doi-asserted-by":"publisher","first-page":"938760","DOI":"10.3389\/fphar.2022.938760","article-title":"Sodium butyrate attenuated diet-induced obesity, insulin resistance and inflammation partly by promoting fat thermogenesis via intro-adipose sympathetic innervation","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3389\/fphar.2019.01040","article-title":"Butyrate improves the metabolic disorder and gut microbiome dysbiosis in mice induced by a high-fat diet","volume":"10","author":"Gao","year":"2019","journal-title":"Front Pharmacol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/ncomms2852","article-title":"The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43","volume":"4","author":"Kimura","year":"2013","journal-title":"Nat Commun"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/gutjnl-2017-314050","article-title":"Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"key":"B134","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1053\/j.gastro.2018.04.017","article-title":"Disruption of epithelial HDAC3 in intestine prevents diet-induced obesity in mice","volume":"155","author":"Whitt","year":"2018","journal-title":"Gastroenterology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"100043","DOI":"10.1016\/j.metop.2020.100043","article-title":"Regulation of hepatic genes related to lipid metabolism and antioxidant enzymes by sodium butyrate supplementation","volume":"7","author":"Honma","year":"2020","journal-title":"Metabol Open"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.5650\/jos.ess22112","article-title":"Dietary supplementation with sodium butyrate reduces high-sucrose diet-induced hepatic accumulation of triacylglycerols and expression of fatty acid synthesis enzymes in rats","volume":"71","author":"Hattori","year":"2022","journal-title":"J Oleo Sci"},{"key":"B137","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jcmgh.2021.05.006","article-title":"Sodium butyrate supplementation inhibits hepatic steatosis by stimulating liver kinase B1 and insulin-induced gene","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"12515","DOI":"10.1038\/s41598-019-48775-0","article-title":"Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans","volume":"9","author":"Muller","year":"2019","journal-title":"Sci Rep"},{"key":"B139","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/gutjnl-2020-323617","article-title":"Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial","volume":"71","author":"Ng","year":"2022","journal-title":"Gut"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e2244912","DOI":"10.1001\/jamanetworkopen.2022.44912","article-title":"Therapeutic effects of butyrate on pediatric obesity: a randomized clinical trial","volume":"5","author":"Coppola","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B141","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4162\/nrp.2023.17.1.164","article-title":"Sodium butyrate inhibits high glucose-induced inflammation by controlling the acetylation of NF-\u03baB p65 in human monocytes","volume":"17","author":"Moon","year":"2023","journal-title":"Nutr Res Pract"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1608658\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T06:06:16Z","timestamp":1753682776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1608658\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":141,"alternative-id":["10.3389\/fcvm.2025.1608658"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1608658","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"article-number":"1608658"}}